Key takeaways:
- Know how to perform stroke and bleeding risk assessment and be able to explain the risks and benefits of treatment to support shared decision-making
- To be able to safely initiate, monitor, and optimise DOAC therapy
- To be able to manage anticoagulation in people with frailty, falls risk and polypharmacy.
- Perform structured anticoagulation reviews and annual monitoring in line with national guidance.
Speakers:
Helen Williams, National Clinical Director for CVD Prevention | Consultant Pharmacist for CVD
Robin Conibere, PCPA SW Regional VP | Lead PCN Pharmacist and Partne